Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
A Clinical Trial to Assess Whether Dexamethasone Addition to Standard Protocols for Non-Traumatic Rhabdomyolysis of Unknown or Genetic Etiologies Improves Patient Outcomes
Children's National Research Institute
50 participants
Oct 1, 2024
INTERVENTIONAL
Conditions
Summary
There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to standard care guidelines. The hypothesis is that patients who receive dexamethasone in addition to standard care versus placebo and standard care will have improvement in pain, length of hospital stay, and decrease in kidney complications.
Eligibility
Inclusion Criteria3
- Diagnosis of rhabdomyolysis defined as creatine kinase> 5000 with trauma excluded
- Ability of parents/patients to understand and the willingness to sign a written informed consent document.
- Patients ages 12 and older will sign written assent
Exclusion Criteria8
- Already taking systemic steroids.
- Inability to comply with study instructions.
- Uncontrolled intercurrent illness or psychiatric illness/social situations that would limit compliance with study requirements.
- Pregnant women.
- o A urine pregnancy test will be performed for women of child-bearing potential.
- Below gestational age of 40 weeks
- Allergy to fluconazole, clotrimazole or nystatin.
- Cannot tolerate PO medications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Steroid five day treatment
Placebo control group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06429982